Fingertips Practice Dashboard (PCN Comparison)
Selected practice
The Woodberry Practice
F85020
PCN: ENFIELD SOUTH WEST PCN
This view compares the selected practice with its PCN average using the same indicator, time period, and visible breakdown where available.
Indicators shown
28
Themes shown
1
Matched PCN rows
28
Average gap
0.62
Top opportunities vs PCN
Record of BMI in the last 12 months for patients on the MH register (denominator incl. PCAs)
Prevalence | 2024/25
83.87
-7.50
Record of a BP check in the last 12 months for patients on the MH register (denominator incl. PCAs)
Prevalence | 2024/25
85.48
-5.85
Smoking: QOF prevalence
Prevalence | 2024/25
12.60
-2.36
Obesity: QOF prevalence (new definition)
Prevalence | 2024/25
11.04
-0.95
Diabetes: QOF prevalence
Prevalence | 2024/25
7.18
-0.81
Mental Health: QOF prevalence
Prevalence | 2024/25
0.95
-0.30
Osteoporosis: QOF prevalence
Prevalence | 2024/25
0.47
-0.15
Dementia: QOF prevalence
Prevalence | 2024/25
0.50
-0.14
Top strengths vs PCN
Total number of prescribed antibiotic items per 1000 registered patients by quarter
Prevalence | 2025 Q3
102.94
+29.83
Patients on the Non-Diabetic Hyperglycaemia register who have had an HbA1c or fasting blood glucose test in the preceding 12 months (denominator incl. PCAs)
Prevalence | 2024/25
87.87
+2.73
Asthma: QOF prevalence
Prevalence | 2024/25
5.44
+0.86
Atrial fibrillation: QOF prevalence
Prevalence | 2024/25
2.03
+0.50
Cancer: QOF prevalence
Prevalence | 2024/25
3.60
+0.45
Depression: QOF prevalence
Prevalence | 2024/25
10.62
+0.26
Hypertension: QOF prevalence
Prevalence | 2024/25
13.12
+0.23
CKD: QOF prevalence
Prevalence | 2024/25
3.90
+0.19
5.44
Asthma: QOF prevalence
2024/25 | %
PCN: 4.58
Gap: +0.86
0.94
COPD: QOF prevalence
2024/25 | %
PCN: 0.98
Gap: -0.04
7.18
Diabetes: QOF prevalence
2024/25 | %
PCN: 7.99
Gap: -0.81
13.12
Hypertension: QOF prevalence
2024/25 | %
PCN: 12.89
Gap: +0.23
87.87
Patients on the Non-Diabetic Hyperglycaemia register who have had an HbA1c or fasting blood glucose test in the preceding 12 months (denominator incl. PCAs)
2024/25 | %
PCN: 85.14
Gap: +2.73
12.60
Smoking: QOF prevalence
2024/25 | %
PCN: 14.96
Gap: -2.36
PCN comparison bar chart
Comparison table
| Indicator | Theme | Breakdown | Time period | Practice | PCN | Gap | Unit |
|---|---|---|---|---|---|---|---|
| Asthma: QOF prevalence | Prevalence | 6+ yrs | 2024/25 | 5.44 | 4.58 | +0.86 | % |
| Atrial fibrillation: QOF prevalence | Prevalence | All ages | 2024/25 | 2.03 | 1.52 | +0.50 | % |
| Cancer: QOF prevalence | Prevalence | All ages | 2024/25 | 3.60 | 3.15 | +0.45 | % |
| CHD: QOF prevalence | Prevalence | All ages | 2024/25 | 2.35 | 2.38 | -0.04 | % |
| CKD: QOF prevalence | Prevalence | 18+ yrs | 2024/25 | 3.90 | 3.72 | +0.19 | % |
| COPD: QOF prevalence | Prevalence | All ages | 2024/25 | 0.94 | 0.98 | -0.04 | % |
| Dementia: QOF prevalence | Prevalence | All ages | 2024/25 | 0.50 | 0.64 | -0.14 | % |
| Depression: QOF prevalence | Prevalence | 18+ yrs | 2024/25 | 10.62 | 10.35 | +0.26 | % |
| Diabetes: QOF prevalence | Prevalence | 17+ yrs | 2024/25 | 7.18 | 7.99 | -0.81 | % |
| Epilepsy: QOF prevalence | Prevalence | 18+ yrs | 2024/25 | 0.75 | 0.61 | +0.14 | % |
| Heart failure with LVSD: QOF prevalence | Prevalence | All ages | 2024/25 | 0.42 | 0.28 | +0.14 | % |
| Heart Failure: QOF prevalence | Prevalence | All ages | 2024/25 | 0.89 | 0.78 | +0.11 | % |
| Hypertension: QOF prevalence | Prevalence | All ages | 2024/25 | 13.12 | 12.89 | +0.23 | % |
| Learning disability: QOF prevalence | Prevalence | All ages | 2024/25 | 0.48 | 0.52 | -0.04 | % |
| Mental Health: QOF prevalence | Prevalence | All ages | 2024/25 | 0.95 | 1.25 | -0.30 | % |
| Non-Diabetic Hyperglycaemia (NDH): QOF prevalence | Prevalence | 18+ yrs | 2024/25 | 9.32 | 9.34 | -0.02 | % |
| Obesity: QOF prevalence (new definition) | Prevalence | 18+ yrs | 2024/25 | 11.04 | 11.99 | -0.95 | % |
| Osteoporosis: QOF prevalence | Prevalence | 50+ yrs | 2024/25 | 0.47 | 0.63 | -0.15 | % |
| PAD: QOF prevalence | Prevalence | All ages | 2024/25 | 0.29 | 0.29 | -0.01 | % |
| Palliative/supportive care: QOF prevalence | Prevalence | All ages | 2024/25 | 0.18 | 0.20 | -0.02 | % |
| Patients on the Non-Diabetic Hyperglycaemia register who have had an HbA1c or fasting blood glucose test in the preceding 12 months (denominator incl. PCAs) | Prevalence | 18+ yrs | 2024/25 | 87.87 | 85.14 | +2.73 | % |
| Proportion of GP registered populations by age group | Prevalence | 15+ yrs | 2025 | 83.16 | 83.16 | 0.00 | % |
| Record of a BP check in the last 12 months for patients on the MH register (denominator incl. PCAs) | Prevalence | All ages | 2024/25 | 85.48 | 91.34 | -5.85 | % |
| Record of BMI in the last 12 months for patients on the MH register (denominator incl. PCAs) | Prevalence | All ages | 2024/25 | 83.87 | 91.38 | -7.50 | % |
| Rheumatoid Arthritis: QOF prevalence | Prevalence | 16+ yrs | 2024/25 | 0.71 | 0.55 | +0.16 | % |
| Smoking: QOF prevalence | Prevalence | 15+ yrs | 2024/25 | 12.60 | 14.96 | -2.36 | % |
| Stroke: QOF prevalence | Prevalence | All ages | 2024/25 | 1.16 | 1.26 | -0.11 | % |
| Total number of prescribed antibiotic items per 1000 registered patients by quarter | Prevalence | All ages | 2025 Q3 | 102.94 | 73.11 | +29.83 | per 1,000 |